Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Fast Diagnosis of Infections Affecting Women

By HospiMedica staff writers
Posted on 07 Jul 2006
A range of new products have been developed to provide fast and efficient diagnosis of women's infections.

Inverness Medical Professional Diagnostics (Princeton, NJ, USA) developed these products, utilizing optical immunoassay (OIA) technology. More...
The BioStar OIA technology permits direct visual detection of the physical change in optical thickness of molecular thin films resulting from the binding reactions between antibodies and antigens. The signal is generated by the change in the reflection of light through the molecular thin films formed on an optical substrate.

White light reflected through the molecular thin film results in a predominant visual background gold color. Changes in the thickness of the optical molecular thin film will alter this gold color. The change occurs when antigens in liquid samples bind with immobilized antibodies. Because this binding reaction increases the thickness of the film, it changes the optical path through it and the gold color changes to blue or purple, indicating a positive result.

The BioStar OIA Streptococcus B test is a simple, rapid diagnostic test that provides results in just 21 minutes and helps monitor mothers during labor and delivery. The test identifies mothers at risk of delivering a group B Streptococcus (GBS) baby directly from cervical or vaginal swabs. This allows time for adequate prevention measures to be commenced, such as antibiotics during delivery, which reduces transmission of GBS from mother to child.

Timing is also the key to tackling chlamydia because one in four patients diagnosed with the disease do not return for follow-up treatment. Rapid diagnosis is vital as treatment delays of as little as three days from the onset of symptoms can result in infertility and/or ectopic pregnancies. A BioStar OIA Chlamydia test meets this need.

The BioStar OIA GC test is a rapid assay for the diagnosis of gonorrhea. BioStar OIA GC is a specific, rapid test for the detection of Neisseria gonorrhoeae (GC) from an endocervical swab for females or from male urine specimens. The BioStar OIA range of tests is designed for use by healthcare professionals in hospitals, clinics, laboratories, and other point-of-care settings.


Related Links:
Inverness Medical Professional Diagnostics

Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Enteral Feeding Pump
SENTINELplus
Newborn Hearing Screener
ALGO 7i
X-Ray Meter
Cobia SENSE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.